Key Market Segments
By Product
- Reagents and Assay Kits
- Instruments
- Consumables and Accessories
- Software and Data Analysis Tools
- Services
- Others (calibration standards, maintenance kits)
By Technique
- Chromatography
- Spectroscopy
- Differential Scanning Calorimetry (DSC)
- Differential Scanning Fluorimetry (DSF)
- Dynamic Light Scattering (DLS)
- Surface Plasmon Resonance (SPR)
By Application
- Drug Discovery and Development
- Biopharmaceutical Production
- Disease Diagnosis and Biomarker Research
- Protein Engineering
- Quality Control and Regulatory Compliance
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others (government laboratories, food & beverage industry labs)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
It helps optimize drug formulation, shelf-life, and efficacy, reducing the risk of clinical trial failures due to protein instability.
Growth is fueled by advancements in thermal analysis, AI integration, and high-throughput screening platforms for biologics.
Key players include Thermo Fisher Scientific, Agilent Technologies, NanoTemper Technologies, Waters Corporation, and PerkinElmer, among others.
The pharmaceutical, biotechnology, and contract research industries are key drivers due to rising demand for stability-indicating methods in drug development.
The market is projected to surpass USD 2.37 billion in 2025, driven by increasing demand for biologics and biosimilar development.